Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ocular Genomics Institute, |
RCV001376504 | SCV001573677 | likely pathogenic | Retinitis pigmentosa 20 | 2021-04-08 | criteria provided, single submitter | research | The RPE65 c.2T>C variant was identified in an individual with retinitis pigmentosa with a presumed recessive inheritance pattern. Through a review of available evidence we were able to apply the following criteria: PVS1, PM2. Based on this evidence we have classified this variant as Likely Pathogenic. |
Labcorp Genetics |
RCV001377675 | SCV001575066 | pathogenic | Leber congenital amaurosis 2; Retinitis pigmentosa 20 | 2023-07-31 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the RPE65 protein in which other variant(s) (p.Pro25Leu) have been determined to be pathogenic (PMID: 18599565, 25972377, 28041643, 30268864). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 98861). Disruption of the initiator codon has been observed in individual(s) with autosomal recessive Leber congenital amaurosis (PMID: 9501220). This variant is not present in population databases (gnomAD no frequency). This sequence change affects the initiator methionine of the RPE65 mRNA. The next in-frame methionine is located at codon 93. |
Retina International | RCV000085190 | SCV000117327 | not provided | not provided | no assertion provided | not provided |